Rhapontigenin was produced from rhapontin isolated from a methanol extract of Rheum undulatum roots by enzymatic transformation. Rhapontin and rhapontigenin exhibited dose-dependent inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells, but the inhibitory activity of rhapontigenin was greater than that of rhapontin. Thus the bioconversion of rhapontin enhanced its ability to inhibit cellular tyrosinase activity and melanin synthesis.
Rhapontigenin was produced from rhapontin isolated from a methanol extract of Rheum undulatum roots by enzymatic transformation. Rhapontin and rhapontigenin exhibited dose-dependent inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells, but the inhibitory activity of rhapontigenin was greater than that of rhapontin. Thus the bioconversion of rhapontin enhanced its ability to inhibit cellular tyrosinase activity and melanin synthesis.
Key words: rhapontigenin; bioconversion; tyrosinase; melanin synthesis inhibition; aglycone
Melanin is a brown-black pigment produced from tyrosine by tyrosinase that is essential in melanin synthesis. 1) Melanogenesis is controlled by an enzyme cascade, and two tyrosinase-related proteins (TRP-1 and TRP-2) are also involved in the pathway.
2) Enzymatic biotransformation of glucosides into aglycones can result in modification of the biological activity of compounds, improving their biological activities. 3, 4) In a previous study, to enhance the bioactivity of rhapontin, isolated from a methanol extract of roots of Rheum undulatum used as a herbal medicine, 5, 6) rhapontigenin was prepared from rhapontin by enzymatic transformation.
7) The compounds were deposited at the Department of Chemical Engineering and Biotechnology, Korea Polytechnic University, Sihung-si, Gyeonggi-do, Korea. In this study, our results indicate that in melanocytes, rhapontigenin exhibits stronger inhibition of tyrosinase activity and melanin biosynthesis than rhapontin.
B16F10 murine melanoma cells (KCLB 80008), purchased from the Korean Cell Line Bank (Seoul, Korea), were routinely cultured in Dulbecco's Modified Eagle's Medium (DMEM, Gibco BRL, Grand Island, NY) containing 10% fetal bovine serum (FBS, Gibco BRL), 50 mg/mL of streptomycin, 50 U/mL of penicillin, and 0.125 mg/mL of amphotericin B in a humidified 5% CO 2 atmosphere at 37 C. All experiments were performed using cells from the same passage. B16F10 melanoma cells (1 Â 10 5 ) were seeded into each well of a 24-well plate. The cells were allowed to attach to the plate for 12 h, and then each test compound at designated concentration or DMSO (control) was added to them. After 2 d of culture, cell viability, tyrosinase activity, and melanin synthesis levels were determined in three independent experiments. All statistical analyses were performed using SigmaStat 3.5 (Jandel Scientific, San Rafael, CA). Differences among groups were evaluated by one-way analysis of variance (ANOVA) and Duncan's multiple range tests. A level of p < 0:05 was set as the threshold for statistical significance.
Cell viability was quantified from mitochondrial activity by colorimetric -(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, St. Louis, MO) assay as reported by Mossman, 8) with minor modifications. Arbutin, a common inhibitor of melanin synthesis, was used as positive control. Following treatment with 40 mM rhapontin, rhapontigenin, and arbutin, cell survival was 92.7, 97.2, and 96.7% respectively, and for 60 mM rhapontin, rhapontigenin, and arbutin, cell survival was 87.4, 92.2, and 90.9% respectively.
Tyrosinase activity was determined as described previously.
9) After culturing for 2 d, cells were harvested and lysed in 1% Triton X-100 and 0.1 mM phenylmethanesulfonyl fluoride (PMSF) in PBS for 30 min to release tyrosinase from the melanosome membrane. The reaction mixture included a 0.05% L-DOPA solution and cell-extracted protein (30 mg) in 0.2 mL of PBS. Dopachrome formation at 37 C was monitored every 10 min for 1 h by measuring the absorbance at 475 nm using a microplate spectrophotometer. Total cells were counted using a hemocytometer, and 2 Â 10 4 cells/mL were treated with various concentrations of the test compounds, followed by the addition of -melanocyte stimulating hormone (MSH, Sigma) (final concentration 100 nM) to stimulate melanin synthesis. To avoid cellular toxicity, the following concentrations were used: 0-50 mM rhapontin or rhapontigenin and 50 mM arbutin. After treatment, tyrosinase activity was as follows: no MSH, 56.4%; MSH plus 50 mM rhapontin, 81.4%; MSH plus 50 mM rhapontigenin, 56.1%; and MSH plus 50 mM arbutin, 73.4% (Fig. 1) . Thus, at the same concentration, rhapontigenin showed greater inhibition of tyrosinase activity than did rhapontin or arbutin. The same level of tyrosinase activity was detected in the cells treated with rhapontigenin and those not treated with MSH.
Melanin content was measured as described previously.
10) The same cell densities and treatments were used to determine melanin content as for tyrosinase activity. Standard curves were constructed using synthetic melanin (Sigma). After treatment, the cellular melanin concentrations were as follows: no MSH, 34.4 mg/mg; MSH alone, 101.6 mg/mg; MSH plus 50 mM rhapontin, 41.4 mg/mg; MSH plus 50 mM rhapontigenin, 29.8 mg/mg; and MSH plus 50 mM arbutin, 68.5 mg/mg ( Fig. 2A) . Thus the lowest concentration of melanin was observed in the cells treated with rhapontigenin, and both rhapontin and rhapontigenin effected greater inhibition of melanin synthesis than the same concentration of arbutin. The MSH-treated cells showed greatly increased melanin synthesis: both the cells and the culture medium were very dark in color (Fig. 2B) .
than those treated with the same concentration of rhapontin, which suggests that rhapontigenin might be useful for skin whitening. The number of hydroxyl groups and the absence of the bulky glycosyl moiety of rhapontigenin, the aglycone of rhapontin, might be important for inhibition of melanogenesis. The structural differences might also play a part in the stronger inhibition of melanogenesis observed for rhapontigenin as compared to rhapontin.
To elucidate the inhibition of melanin synthesis by rhapontin and rhapontigenin, we investigated the expression of melanogenic enzymes, tyrosinase, TRP-1, and TRP-2, by Western blotting. Tyrosinase, TRP-1, TRP-2, and actin were detected with rabbit polyclonal anti-tyrosinase antibody, rabbit polyclonal anti-TRP-1 antibody, and rabbit polyclonal anti TRP-2 antibody respectively, purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and with secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG antibody) (Santa Cruz Biotechnology). All bound antibodies were then detected with enhanced chemiluminescence (ECL) reagent (Perkin Elmer, Waltham, MA). Rhapontin and rhapontigenin inhibited the expression levels of the melanogenic enzymes in B16F10 cells (Fig. 3A) . Rhapontigenin mainly suppressed the expression levels of tyrosinase and TRP-1 as compared to a control treated with MSH alone. The protein content of the sample treated with MSH alone was taken to be 100%. The levels of tyrosinase, TRP-1, and TRP-2 fell to 68.6%, 64.6%, and 90.7% respectively after treatment with 50 mM rhapontigenin and MSH; to 90.5%, 79.5%, and 88.4% respectively after treatment with 50 mM rhapontin, and MSH; and to 65.8%, 98.2%, and 93.9% respectively after treatment with 50 mM arbutin and MSH.
Gene expression of the melanogenic enzymes was investigated by real-time PCR. After preparation of cDNA using a Revert Aid First Strand cDNA kit (Fermantas, St. Leon-Rot, Germany), quantitative PCR was performed in a CFX96 Real-Time PCR System (Bio-Rad, Hercules, CA). The oligonucleotide primers for tyrosinase, TRP-1, TRP-2, and actin were synthesized as previously reported.
11) A reaction without cDNA was used as negative control. For relative quantification of gene expression on the basis of the same amounts of RNA (1 mg), the average threshold of detection (the Ct value) for each gene was obtained, and delta Ct (ÁCt ¼ Ct target gene À Ct reference gene ) was calculated using the Ct values of the genes in the same sample. The actin gene was used as internal control reference gene. The ÁÁCt value was obtained by calculation by the equation ÁÁCt ¼ ðÁCt treated À ÁCt untreated ). The normalized expression fold was expressed as the value of 2
ÀÁÁCt (actin control = 1).
12)
Gene expression of the melanogenic enzymes was also suppressed (Fig. 3B) . Compared with the normalized fold expression of tyrosinase and TRP-1 in the sample treated with MSH only, tyrosinase mRNA decreased to 55.4%, 17.1%, and 12.0%, and TRP-1 mRNA decreased to 62.8%, 46.6%, and 14.3% in samples treated with MSH plus arbutin, MSH plus rhapontin, and MSH plus rhapontigenin respectively. TRP-2 mRNA remained relatively constant. These results indicate that rhapontin and rhapontigenin inhibited melanin synthesis by reducing the expression of tyrosinase and TRP-1 in melanocytes. In this study, similar levels of tyrosinase activity were detected in untreated (no MSH) and rhapontigenin-treated cells, but the melanin concentration was lower in the latter group. Overall, our findings indicate that rhapontin and rhapontigenin inhibit melanin synthesis to a greater extent than cellular tyrosinase activity, which suggests that tyrosinase inhibition is not the sole mechanism of inhibition of melanin synthesis.
-MSH stimulates melanin synthesis through upregulation of pigmentary genes, which is associated with increases in tyrosinase, TRP-1, and TRP-2. Although tyrosinase protein was slightly decreased by rhapontin, the expression of melanogenic enzymes was decreased by rhapontin and rhapontigenin. These results correlate with clear downregulation of their genes in samples treated with rhapontin and rhapontigenin. Hence, the results suggest that the effects of rhapontin and rhapontigenin on inhibition of melanin synthesis are due mainly to a reduction in melanogenic enzymes expression, and that rhapontigenin suppressed gene expression of the melanogenic enzymes more than rhapontin.
In conclusion, our results confirm that rhapontin isolated from roots of R. undulatum inhibits cellular tyrosinase activity and melanin synthesis in cultured melanocytes. Moreover, enzymatic transformation of rhapontin to rhapontigenin enhances the inhibition of melanin biosynthesis by suppressing the expression of melanogenic enzymes. This suggests that rhapontigenin might be suitable for use as a skin-whitening agent. 
